Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „prolongation“
Suchtreffer
Begriffe & Kennungen
Kaletra · 4.5 · 54 Delamanid (100 mg Delamanid: Due to the risk of QTc prolongation BID) AUC: ↑ 22% associated with DM-6705, i
Eintrag öffnenKaletra · 4.5 · Delamanid (100 mg Delamanid: Due to the risk of QTc prolongation BID) AUC: ↑ 22% associated with DM-6705, if c
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · Monitoring of QT-prolongation if used concomitantly. Bortezomib Bortezomib: Careful monitoring. Busulfan AUC:
Eintrag öffnenKisplyx · 4.8 · Hypocalcaemia (see section 4.4, QT interval prolongation)
Eintrag öffnenKisplyx · 4.8 · QT interval prolongation (see section 4.4)
Eintrag öffnenKisqali · 4.8 · QT prolongation In the phase III study in patients with early breast cancer, 5.3% of patients in the Kisqali p
Eintrag öffnenKrazati · 4.8 · QT interval prolongation resulted in dose interruption and/or reduction in 3.4% of patients (see sections 4.2
Eintrag öffnenKrazati · 4.8 · QT prolongation Any grade increase in QTcF interval from baseline occurred in 43.9% of patients. Increase in Q
Eintrag öffnenLebenserhaltende Behandlung
Eintrag öffnenLenvima · 4.8 · Females had a higher incidence of hypertension, fatigue, ECG QT prolongation and alopecia. Men had a higher in
Eintrag öffnenLenvima · 4.8 · In the Phase 3 REFLECT trial (see section 5.1), QT/QTc interval prolongation was reported in 6.9% of lenvatini
Eintrag öffnenLenvima · 4.8 · In the Phase 3 Study 309 (see section 5.1), QT interval prolongation was reported in 3.9% of lenvatinib plus p
Eintrag öffnenLenvima · 4.8 · In the pivotal Phase 3 SELECT trial (see section 5.1), QT/QTc interval prolongation was reported in 8.8% of le
Eintrag öffnenLenvima · 4.8 · QT interval prolongation (see section 4.4)
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · Delamanid (100 mg Delamanid: Due to the risk of QTc prolongation BID) AUC: ↑ 22% associated with DM-6705, if c
Eintrag öffnenNexavar · 4.8 · Ear and tinnitus labyrinth disorders Cardiac congestive QT disorders heart failure* prolongation myocardial is
Eintrag öffnenNoxafil · 4.8 · 52 QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnenNoxafil · 4.8 · QTc prolongation QTc prolongation has been reported with the use of posaconazole (see section 4.4).
Eintrag öffnen